Press Releases
AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases
Advancing next-generation RESTORE+™ RNA editing platform based on pioneering research of founders Thorsten Stafforst and Jin Billy Li
Publications
Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides
Merkle T, Merz S, Reautschnig P, Blaha A, Li Q, Vogel P, Wettengel J, Li JB, Stafforst T. Nat Biotechnol 2019, 37:133-138, doi: 10.1038/s41587-019-0013-6, PMID: 30692694.
An RNA-deaminase conjugate selectively repairs point mutations
Stafforst T, Schneider MF. Angew Chem Int Ed Engl 2012, 51:11166-11169, doi: 10.1002/anie.201206489, PMID: 23038402.